Robert T. Foster

Insider Reports History

Entity
Individual
Location
C/O Contravir Pharmaceuticals, Inc., 399 Thornall Street, First Floor, Edison, NJ
Signature
/s/ Dr. Robert T. Foster
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert T. Foster:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Hepion Pharmaceuticals, Inc. CEO and Director, Director Common Stock 50.5K $154K $3.05 Sep 18, 2023 Direct
Aurinia Pharmaceuticals Inc. Director Stock Option (right to buy) 32.9K Sep 21, 2023 Direct
Aurinia Pharmaceuticals Inc. Director Restricted Stock Units 20.4K Sep 21, 2023 Direct

Insider Reports Filed by Robert T. Foster

Symbol Company Period Transactions Value $ Form Type Date Filed Role
AUPH Aurinia Pharmaceuticals Inc. Sep 21, 2023 2 $0 4 Sep 22, 2023 Director
AUPH Aurinia Pharmaceuticals Inc. Sep 21, 2023 0 $0 3 Sep 22, 2023 Director
HEPA Hepion Pharmaceuticals, Inc. Sep 18, 2023 1 $8.96K 4 Sep 19, 2023 CEO and Director, Director
HEPA Hepion Pharmaceuticals, Inc. Sep 15, 2023 1 $8.64K 4 Sep 18, 2023 CEO,CSO and Director, Director
HEPA Hepion Pharmaceuticals, Inc. May 18, 2021 1 $0 4 May 20, 2021 CEO, CSO and Director, Director